Navigation Links
NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection

HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish medtech company focusing on developing innovative Nitric Oxide-containing medical devices, today reported that it has achieved another important milestone in the development of a new preventive therapy against urinary tract infection, UTI.

In experiments performed at the Karolinska University Hospital in Sweden, researchers showed that technology developed by NOLabs AB proved to have a high effectiveness in killing pathogens, typically for those causing UTI including an aggressive strain of E. coli. Millions of patients annually acquire UTI while being hospitalized for treatment of other diseases. Preventing such infection has the potential to dramatically reduce the amount of antibiotics used as well as improving quality of life for a large number of hospitalized patients.

Goran Beijer, CEO of NOLabs says; "We are happy to have taken another important step in developing products that have a huge potential to prevent millions of UTI cases globally every year. The anti-microbial effect of NO will be essential in a range of innovative products that prevent and/or treat infection. We expect to have the first products on the market in early 2009."

Professor Peter Wiklund, Karolinska University says; "This new technology has a huge potential to reduce the usage of Antibiotics and thereby the risk of antibiotic resistance as well as reducing the risk of urosepsis, the severest and potentially lethal consequence of UTI."

NOLabs is developing products that will prevent catheter related urinary tract infections, products that will be effective on reducing neuropathic pain and wound care products with an anti-bacterial effect.

NOLabs is a Swedish bio-medtech company focusing on the development and marketing of Nitric Oxide-containing medical devices for various medical applications. Nitric Oxide is a natural substance, produced by the human body controlling vaso-regulation and as part of its protection against pathogens. In particular, NOLabs focuses on developing effective Nitric Oxide based products and therapies that prevent infection and provide pain relief for millions of patients suffering from diabetes-related complications such as chronic wounds and neuropathic pain. Another focus area is the prevention and treatment of urinary tract infections. NOLabs has developed innovative, cost efficient and highly effective technologies that have a significant potential to address serious health issues that impact the lives of over 100 million people.

Goran Beijer


Phone: +46-706-636-009

Susanne Goransson

Phone: +46-42-33-65-21

Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015 WuXi PharmaTech ... and technology platform company serving the pharmaceutical, biotechnology, ... has launched a mobile version of OncoWuXi, the ... to access oncology models and data on the ... and at any time to identify relevant tumor ...
(Date:10/13/2015)... 13, 2015 Health Gorilla ( ) today ... – a secure platform for clinical data and communications ... about and manage healthcare in the US. The launch follows ... a combined total of $4.4M raised to date, with ... True Ventures , Harris Barton , Orfin Ventures ...
(Date:10/13/2015)... DUBLIN , Oct. 8, 2015 Research ... of the "World Anti-counterfeit Pharmaceuticals and Cosmetics Packaging ... report to their offering. --> ... packaging market to grow at a CAGR of 15.7% ... The hologram authentication technology segment accounted for about ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... ... the United States, today announced the release of its limited edition holiday seasonal ... Cocktail Agua Fresca. All feature the unique flavor combinations and delicious taste Califia ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ProText Kinetic Panel ... . With ProText Kinetic Panel, users can create energetic text animations in any layout ... into the Final Cut Pro X timeline and stylize the text. With intuitive on-screen ...
(Date:10/13/2015)... , ... October 13, 2015 , ... In an age ... costs were 36 percent lower per square foot than in 2009. The Williamsport Regional ... of heating and cooling has decreased by eight percent. , According to Facilities ...
(Date:10/13/2015)... York, NY (PRWEB) , ... October 13, 2015 , ... ... The app helps individuals find others to train with, participate in local fitness ... App Store and Google Play. , “As high medical costs drive us to get ...
(Date:10/13/2015)... ... October 13, 2015 , ... Altec Products, Inc., the ... of Synergy 2015. The annual WennSoft KEY2ACT user conference will take place from ... unite customers, partners, WennSoft team members and sponsors to facilitate the sharing of ...
Breaking Medicine News(10 mins):